Loading clinical trials...

Effect of Flavored, Carbonated Drinks on Salivary Flow, Salivary Composition, and Taste Perceptions | Clinical Trials | Clareo Health

RECRUITINGNA

Effect of Flavored, Carbonated Drinks on Salivary Flow, Salivary Composition, and Taste Perceptions

NCT06933290•PepsiCo Global R&D

View on ClinicalTrials.gov

Summary

To determine the effect of flavored, carbonated drinks on salivary flow rate, saliva composition, and taste perceptions compared with control drinks (water, carbonated water, non-carbonated)

Detailed Description

Previous studies have shown that drinking a beverage can stimulate the production of saliva and alter its composition. These effects could impact oral processing and taste perceptions. Various ingredients in beverages such as carbonation may affect saliva and oral processing. The objective of this study is to determine the effect of flavored carbonated beverages on salivary flow rate, saliva composition (pH, mucins, carbonic anhydrase, and total protein), and taste perceptions compared with unflavored and non-carbonated control drinks.

Eligibility

Age

18 - 45 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Subject is male or female
•If female, subject is not pregnant or nursing (based on self-report)
•Subject is 18-45 years of age, inclusive
•Subject is a regular consumer of carbonated drinks (questionnaire)
•Subject is willing to avoid alcohol consumption 24 hours prior to visits
•Subject is willing to fast (no food or gum) for 2 hours prior to study sessions
•Able to speak, write, and read English
•Provision of written consent to participate

Exclusion Criteria

•Subject smokes, vapes, or uses any nicotine/tobacco products (or has quit for less than 6 months)
•Subject currently has or recently had an illness (cold, flu, COVID) within the past month
•Subject has a condition affecting the oral cavity such as Xerostomia (dry mouth), Sores/lesions, Untreated dental caries, Major dental implants/appliances (including dentures)
•Subject has a reduced sense of taste (dysgeusia) or smell (parosmia)
•Subject has a health condition that would interfere with the study as indicated on the general health questionnaire (GHQ) (including cardiovascular, renal, or metabolic diseases)
•Subject has participated in a clinical trial within the past 30 days
•Subject has participated in any PepsiCo trial within past 6 months
•Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk
•Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any PepsiCo product. If subject is unsure if a company would be considered a competitor to PepsiCo, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.

Locations (1)

Gatorade Sports Science Institute

Valhalla, New York, United States

Key Dates

Start Date

March 24, 2025

Primary Completion Date

June 13, 2025

Completion Date

June 29, 2025

Last Updated

April 18, 2025

Enrollment

ESTIMATED participants

Conditions

Taste PerceptionSaliva Production

Interventions

Beverage

OTHER

Contacts

Lindsay Baker, PhD

CONTACT

814-883-9454 Lindsay.Baker@pepsico.com

Umami Taste Intensity and Meal Intake

NCT07421466

Taste SensitivityUmami Taste Perception+3 more

View study

COMPLETEDNA

The Effect of Dietary Sugar Consumption on Sweet Taste Perception

NCT02090478

Sweet Taste Perception

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 18, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions